• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-40
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anemia (1706); Ecchymosis (1818); Fever (1858); Hematoma (1884); Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914); Hypovolemic Shock (1917); Unspecified Infection (1930); Infiltration into Tissue (1931); Sepsis (2067); Septic Shock (2068); Swelling (2091); Complaint, Ill-Defined (2331); Sweating (2444); Abdominal Distention (2601); Test Result (2695)
Event Date 09/13/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a foreign healthcare professional (hcp) via a clinical study regarding a patient receiving intrathecal therapy. The drug, dose, and concentration were unknown. The indication for use was not reported. It was reported the patient developed a post-operative hematoma following a pump replacement on (b)(6) 2018. The patient was sweaty, developed hypotension, and experienced swelling around the pump with ecchymosis. The event resulted in in-patient hospitalization, prolongation of existing hospitalization, an emergency room visit, and an urgent care visit. An echography of the abdomen on (b)(6) 2018 confirmed a large hematoma around the pump on the right side. There was no intra-abdominal free fluid. The hematoma was removed, and surgical observation on (b)(6) 2018 revealed ¿active bleeding median cranial in the wound¿; coagulation of the bleeding in the wound occurred. The event resulted in a life-threatening illness or injury and resulted in medical or surgical intervention to prevent life threatening illness or injury or permanent impairment to a body structure or a body function. Conflicting information classified the hematoma removal as ¿medical or non-surgical intervention¿. X-rays of the thorax on (b)(6) 2018 showed no pleural fluid, no compactions, and no pneumothorax. The event was possibly related to the device/therapy and possibly related to the implant procedure. The event was ongoing.
 
Manufacturer Narrative
Test results refer to laboratory testing on 2018 (b)(6) showed a hemoglobin decrease, lower kidney function, and higher lactate. If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a foreign healthcare professional (hcp) via a study. It was reported the patient went into hypovolemic shock. On 2018 (b)(6), vancomycin was administered, and the patient underwent a blood transfusion. Laboratory testing on 2018 (b)(6) showed a hemoglobin decrease, lower kidney function, and higher lactate. Echography of the abdominal wall on 2018 (b)(6) showed normal results. The patient was alert. The event resolved without sequelae on 2018 (b)(6). ¿other etiology¿ noted the cause of the event was unknown, and it was later clarified the event was related to the implant procedure. No further complications were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a foreign healthcare professional (hcp) via a study. It was reported the patient's height and weight were not measured.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a foreign healthcare professional (hcp) via a study. It was reported the event was "possibly" related to the implant procedure.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient was receiving baclofen (500 mcg/ml at 160. 2086 mcg/day).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a foreign healthcare professional (hcp) via a study. It was reported that sepsis occurred on (b)(6) 2018. At urgency care, the patient developed a 'shock' image, probably based on a hypovolemic and septic component. On (b)(6) 2018, there was a respiratory focus with fever until 38. 2°c, sputa and ¿decreased vag¿ on the right. An x-ray showed an infiltration right infrahilar. Piperacillin/ tazobactam + 1x vancomycin were administered for the sepsis on (b)(6) 2018. Tazocin-vancomycin, levophed, vasopressin and intravenous fluid suppletion were administered on-(b)(6) 2018. Oxygen therapy was also administered on (b)(6) 2018. Examination on (b)(6) 2018 showed a lightly bloated belly with palpable baclofen pump, limited subcutaneous crepitations, and no tension (pain). There was no blood loss. Device interrogation/device data on (b)(6) 2018 showed normal results. An echography of the abdomen on (b)(6) 2018 showed an important decrease of the subcutaneous hematoma around the pump. Active bleeding could not be excluded on this echo.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a foreign healthcare professional (hcp) via a study. It was reported that the cause of the event was unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSYNCHROMED II
Type of DevicePUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key7897912
MDR Text Key121016394
Report Number3004209178-2018-21232
Device Sequence Number1
Product Code LKK
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Reporter Occupation
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 12/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/21/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Expiration Date01/14/2020
Device Model Number8637-40
Device Catalogue Number8637-40
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received12/20/2018
Was Device Evaluated by Manufacturer? No Answer Provided
Date Device Manufactured07/16/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 09/21/2018 Patient Sequence Number: 1
-
-